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An Exploration of the Association of Patient Characteristics and 
Pharmacological Treatments to Inpatient Falls among Patients At-risk for 
Falling during Hospitalization 
 







Introduction/Background: Falls may be the most commonly reported incidents in the acute care setting, and a 
frequent cause of harm in the hospital. Studies have focused on identifying risk factors for falls and interventions 
aimed at reducing the risk of falling.  The purpose of this study was to describe and compare patient characteristics 
and pharmacological treatments between patients who fell and patients who did not fall, among a sample of patients 
deemed to be at-risk for falling during hospitalization. Additionally, the study aimed to identify independent predictors 
of falls among patients at-risk for falls during hospitalization. 
Methods: An observational, cross-sectional study involving the analysis of retrospective patient records.  A 
convenience sample of all patients with a Morse Fall Scale of >45 over a 1-year period, was extracted from electronic 
medical records.  Descriptive statistics of demographic characteristics and medication classes were generated to 
compare those who fell to those who did not fall.  To examine significant predictors of falls, logistic regression 
(univariate and multivariable) were employed.  
Results/Findings: The sample consisted of 4,978 valid patient records.  White non-Hispanics constituted 60% of the 
falls group but only 24% of the non-falls group.  A larger proportion of those who fell received antiemetics or insulin 
compared to those who did not fall. Univariate regression analysis found that race and 39 medication classes were 
independently associated with falls.  Multivariable regression analysis showed that race and 11 medication classes 
were associated with the odds of falling. 
Conclusions: White patients were more likely to fall than patients of other races.  New associations were found 
between the odds of falling and antiprotozoals, diagnostic agents, and gastrointestinal agents.  Prospective studies are 
needed to determine the predictive accuracy of these factors. Bedside practitioners should understand the mechanism 
and onset of action of medications so that individualized safety precautions may be implemented.  By including classes 
of medications as part of fall-risk assessment, patient safety may be optimized and falls avoided in this high risk 
population. 
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INTRODUCTION 
 
Falls continue to present a major patient safety 
concern both in the community and in hospitals. In 
2015, direct medical costs for fatal falls were estimated 
at $637.5 million and $31.3 billion for non-fatal injuries 
(Burns, et al., 2016). Falls is one of the most frequent 
causes of harm in the hospital.  Bouldin et al., (2013) 
reported a prevalence rate of 3.56 per 1000 patient days 
and an injury rate of 0.93 per 1000 patient days. Thus, 
regulatory agencies, such as the Centers for Medicare 
and Medicaid Services  (CMS)  and  The  Joint 
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Commission (TJC), have placed great emphasis on fall 
prevention programs and have included this as a 
requirement for billing and accreditation (Quigley & 
White, 2013). 
 
Definition of Falls 
The National Database of Nursing Quality 
Indicators (NDNQI) in its 2016 guidelines, defined a 
patient fall as an unplanned descent to the floor with or 
without injury to the patient.  NDNQI reports two fall 
indicators (rate of total falls per 1000 patient-days and 
the rate of falls with injury per 1000 patient-days), 
which were endorsed by the National Quality Forum. 
 
Factors Associated with Falls 
Studies focused on the prevention of falls have 
attempted to identify the factors that contribute to fall 
risk (Deandrea, et al., 2013; Dykes, Hurley, Benoit, & 
Middleton, 2009) as well as interventions (Dykes et al., 
2010) that may help reduce the risk for falling in the 
acute care setting. Incorporating an externally validated 
instrument, such as Morse Fall scale, into the electronic 
medical record has been identified as an important 
strategy in identifying patients at-risk for falling 
(DuPree & Musheno, 2014). However, due to the 
multifactorial nature of falls, even externally validated 
tools have not been able to accurately assess the risk of 
falling on a consistent basis (Williams, Szekendi & 
Thomas, 2014).   
Some studies have focused on identifying the 
modifiable and non-modifiable risk factors that may 
predict patient falls such as patient characteristics, fall 
risk assessment, unassisted ambulation, medications, 
bathroom-related/toileting, bed and chair alarms, call 
light, environment and equipment, handoff communi-
cation, education, and change management (DuPree & 
Musheno, 2014).  Additionally, gait/balance deficit or 
lower extremity problems, confusion, use of 
sedatives/hypnotics, use of diabetes medications, 
increasing patient-to-nurse ratio and activity level of 
“up with assistance” compared with “bathroom 
privileges” were found to be associated with increased 
risk of falling (Krauss et al., 2005).   
An exploratory research conducted by Tzeng and 
Yin (2008) found that only 13.5% of falls examined 
were medication-related falls.  A more recent work 
found that pain medications/opiates, cardiac 
drugs/antihypertensives, sedatives/hypnotics, and anti-
psychotics/ antidepressants were commonly taken by 
patients within the 24 hour period just prior to a fall 
(Williams, Szekendi & Thomas, 2014).  These findings 
were similar to the study findings of Krauss and 
colleagues (2005) in which nonnarcotic analgesics, 
antiarrythmic agents, and sedatives/hypnotics were 
associated with falls, in addition to diabetes 
medications. 
In summary, with the exception of the study by 
Krauss et al. (2005) and Anderson, Dolansky, Damato, 
and Jones (2014), most studies have been descriptive in 
nature and no attempt was made to determine what 
factors actually predicted the occurrence of falls among 
hospitalized patients (DuPree & Musheno, 2014; Tzeng 
& Yin, 2008; Williams, Szekendi, & Thomas, 2014).  
In Krauss et al. (2005), patients who fell were compared 
to patients who did not fall during hospitalization on a 
variety of potential predictors.  The patients included in 
the study were assessed to be at varying levels of risk 
for falling on admission, therefore it is difficult to 
determine to what extent pre-existing risk may have 
confounded or contributed to the findings of the study.  
A more recent study conducted by Anderson et al. 
(2014) indicated that male gender and age greater than 
65 were predictive of serious fall injury among 
hospitalized patients. Yet, there has been little research 
focusing on subgroups of patients at varying levels of 
risk for falling or the identification of factors associated 
with the occurrence of falls within such subgroups.   
The present study focused on patients assessed to 
be at high risk for falling during hospitalization.  The 
characteristics of those who actually fell were 
compared to those who did not fall and significant 
predictors were identified. 
The study aims were to: 
 
1. Describe the distribution of certain patient 
characteristics and pharmacological treatments 
among patients at-risk for falling during 
hospitalization. 
2. Compare those who actually fell to those who 
were at-risk but did not fall during 
hospitalization for significant differences in 
patient characteristics and prescribed 
pharmacological treatments. 
3. Determine the association of patient 
characteristics to the occurrence of falls 
among patients at-risk for falling during 
hospitalization. 
4. Determine the association of pharmacological 
treatments to the occurrence of falls among 
patients at-risk for falling during 
hospitalization. 
5. Identify independent predictors of falls 




   
Institutional review board approval for the study 
was obtained in September of 2015.  A waiver of 
informed consent was obtained since the study was of 
minimal risk and did not involve identifiable patient 
information, interventions or changes in patient care.
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A cross-sectional observational design was utilized 
to examine similarities and differences between 
patients who fell and patients who did not fall during 
their period of hospitalization.  All medical records data 
included in the study were collected retrospectively.  
 
Setting 
The study was conducted at a 148-bed community 
hospital in southeastern United States.  The patient 
population was racially and ethnically diverse; 
according to the U.S. Census Bureau (2010), the 
surrounding community is approximately 58% 
Hispanic, 31% Black, 10% White, and 1% other races.  
The hospital’s unique location, surrounded by farmland 
but only 40 miles from a major metropolitan city 




A convenience sample of 5,356 records from 
inpatients deemed to be at high-risk for falling at any 
point during hospitalization between July 1st, 2014 and 
June 30th, 2015 were included in the study.  Patient-
level data was extracted from electronic medical 
records, as well as administrative and clinical pharmacy 
databases.  A pseudo identification number was 
assigned to each patient record. Medical record 
numbers were not retained in the study database.  
Patient records were included in the study if they had a 
documented Morse Fall Scale score of 45 or greater, 
indicating high-risk for falling at any point during 
hospitalization.  Excluded from the study were 
outpatients and the records of patients with all recorded 
Morse Fall Scale scores of less than 45, no documented 
Morse Fall Scale score, and those with no Morse Fall 
Scale score documented prior to falling.  After 
screening for inclusion and exclusion criteria, and the 
removal of 378 patient records with unrealistic or 
missing height and weight measurements, a total of 
4,978 records were found eligible for the study. 
 
Measures 
Variables representing patient characteristics were 
selected based on the extant literature linking certain 
patient characteristics to the occurrence of falls during 
hospitalization and the researchers’ determination of 
factor’s within the hospital’s unique patient population 
that may have contributed to falls. Patient 
characteristics measured on a continuous scale were 
age, height, and weight; categorical measures included 
patient gender, race, preferred language, insurance 
status, history of smoking, history of alcohol use, and 
primary admission diagnosis.  In addition, the impact 
of patient comorbidities on the occurrence of falls 
during hospitalization was assessed using the Charlson 
Comorbidity Index (CCI).  The CCI is a weighted index 
of 19 patient comorbidities, with demonstrated 
predictive validity for several hospital outcomes 
including complications, length of stay, mortality 
(Charlson, Szatrowski, Peterson & Gold, 1994; 
Johnson et al., 2015; Schmolders et al., 2015).  By 
determining the presence or absence of the included 
comorbidities and adding their associated weights 
(which range between 1 and 6 points), a risk score is 
generated; higher scores indicate higher risk for 
mortality.  Since its inception, the CCI has undergone 
several revisions, in this study scoring of the CCI was 
based on an updated version of weights and 
International Classification of Diseases 9th Edition 
(ICD-9) diagnostic codes representing patient 
comorbidities (Quan et al., 2005; Quan et al., 2011). 
Variables representing pharmacological treatments 
were coded based upon major drug classification.  
Since the initial data was received in the form of 
generic drug names or brand names, members of the 
research team recoded each drug into their major drug 
classifications in accordance with the American 
Hospital Formulary Service (AHFS) – 2016 Drug 
Formulary and under the guidance and discretion of a 
research team member with pharmacological expertise.  
A total of 131 major drug classifications were 
represented within the sample. 
 
Analysis 
Analyses were conducted using RStudio 0.97.551 
(R Studio, 2013) incorporating R 3.2.1 (R Core Team, 
2015) open source statistical analysis software.  
Descriptive statistics using frequencies, percentages, 
and measures of central tendency were generated for 
the overall sample and subgroups of patients who fell 
and did not fall (study aims “1” & “2”).  Univariate 
logistic regression analysis was conducted to identify 
factors associated with patient falls (study aims “3” & 
“4”); variables with a p < .20 were considered 
significant and were retained for multivariable 
modeling. Multivariable logistic regression using 
backward elimination was conducted to identify 
independent predictors of patient falls (study aim “5”); 
variables with a p < .10 were retained and used to build 




Of the 4978 records included in the analysis, only 
40 (0.80%) patients actually fell during their period of 
hospitalization while the remaining 4,938 did not fall. 
Table 1 provides a complete description of the sample 
demographics. Eight of the ten most frequently 
occurring medication classifications were similar for  
the overall sample, the subgroup that did not fall, and 
the subgroup that fell (Table 2).  The administration of  
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those medications range from 40.8% to 83.2% of the 
sample. However, antiemetics and insulins were found 
to be among the ten most frequent medication classes 
for those who fell but not among those who did not fall. 
Table 1 
 
Subgroup Comparison based on Fall Status (Did Not Fall, Fell) and Description of the Overall Sample (N=4978) 
 
 Did not Fall (n = 4938) Fell (n = 40) Overall sample (n = 4978) 
  n (%)  M (sd) n (%) M (sd) n (%) M (sd) 
Age -- 61.8 (18.9) -- 59.5 (16.4) -- 61.8 (18.9) 
Gender 
  Male 












  White Hispanic 
  White Non-Hispanic 
  Black/African American 
  Black Hispanic  
  Other 











 1 (2.5%) 
 0 (0%) 










  English 
  Spanish 
  Creole 

















  Insured 
















  Yes 
















  Yes 

























































































Description of Top Ten Medication Classifications by Subgroup and for the Overall Sample (N = 4978) 
 
Did not Fall (n = 4938) Fell (n = 40) Overall Sample (n = 4978) 
Medication Classification n (%) Medication Classification n (%) Medication Classification n (%) 
Replacement Preparations 4143 (83.9%) Replacement Preparations 37 (92.5%) Replacement Preparations 4143 (83.2%) 
Anticoagulants 3724 (75.4%) Anticoagulants 31 (77.5%) Anticoagulants 3724 (74.8%) 
Proton-pump Inhibitors 3350 (67.8%) Proton-pump Inhibitors 30 (75.0%) Proton-pump Inhibitors 3350 (67.3%) 
Antibacterials 3144 (63.7%) Antibacterials 30 (75.0%) Antibacterials 3144 (63.2%) 
Opiate Agonists 2889 (58.5%) Opiate Agonists 29 (72.5%) Opiate Agonists 2889 (58.0%) 
NSAIDSa 2145 (43.4%) Anticonvulsants 26 (65.0%) NSAIDSa 2145 (43.1%) 
Benzodiazepines 2141 (43.4%) Benzodiazepines 26 (65.0%) Benzodiazapines 2141 (43.0%) 
Beta-Adrenergic Blockers 2103 (42.6%) Antiemetics 24 (60.0%) Beta-Adrenergic Blockers 2103 (42.3%) 
Anticonvulsants 2082 (42.2%) Analgesics/Antipyretics 21 (52.5%) Anticonvulsants 2082 (41.8%) 
Analgesics/Antipyretics 2033 (41.2%) Insulins 19 (47.5%) Analgesics/Antipyretics 2033 (40.8%) 
Note.  aNSAIDS = Non-steroidal anti-inflammatory drugs. 
 
Results of Univariate Regression 
A total of 142 predictor variables were available to be 
regressed against fall status, including 131 variables 
representing a variety of major medication classifications. 
Univariate logistic regression found 40 significant (p < 
.20) predictors of patient falls.  From these results, only 
race was retained among the demographic variables, 
the remaining 39 were representative of major 
medication classifications.  These results are presented 
in Table 3.  
 
Results of Multivariable Regression Analysis 
Prior to multivariable regression, racial categories 
were collapsed into three groups (“White Hispanic”, 
“Black/African American”, “White-Non Hispanic and 
Other”).  We created the “White Non-Hispanic and 
Others” category from the “White”, “Asian/Pacific 
Islander”, “Black Hispanic” and “Other” race 
categories since there was no significant difference 
among these categories at the 5% significance level 
based on results from the univariate regression. The 
“White Non-Hispanic and Others” category was then 
used as reference category for race in the multivariable 
model. The multivariable model was then constructed 
which included race and the 39 medication classes from 
the univariate model. The results of the multivariable 
analysis are presented in Table 4.  
Considering the limited number of fall events and 
a high number of redundant medication classes found 
in the results (Table 4), we desired to reduce this model 
further. We built a new multivariable logistic 
regression model and excluded medication classes that 
did not have a p-value < .10 from the previous model. 
The final model is presented in Table 5. The Likelihood 
Ratio Test (LRT) indicated that the overall model was 
significant [χ2(13) = 78.31, p = .000].  Each of the 12 
variables included in the model were significant 
predictors of fall status.  The odds of falling for the 
Black/African American group was almost 3 times 
lower, and the White Hispanic group was more than 6 
times lower compared to patients of White-Non 
Hispanic and Other races.  Most of the medication classes 
than 13 times lower odds of falling.  Patients who were 
administered gastrointestinal drugs-miscellaneous 
classification had odds of falling that were more than 
49 times higher, barbiturates more than 10 times higher, 
diagnostic agents 6 times higher, centrally acting 
skeletal muscle relaxants by almost 5 times higher than 
those who were not.  In addition, patients who were 
administered antiparkinsonian agents had an odds of 
falling about 4.5 times higher, general anesthetics by 
about 4 times higher, thiazide diuretics by more than 3 
times higher, local anesthetics by almost 3 times higher, 
autonomic drugs-miscellaneous by about 2.6 times 
higher, and antiemetics 2.4 times higher than those who 




In this study, the investigators observed that White 
Hispanics and Black/African Americans had lower 
odds of falling compared to other races. While White 
Hispanics and Black/African Americans together 
constituted about 68% of the sample, White Non-
Hispanics were only 24% of the sample but constituted 
60% of the group that experienced falls.  Most of the 
previous studies looked at the association of other 
patient characteristics such as age and gender 
(Deandrea et al., 2016; Williams, Szekendi, & Thomas, 
2014) to the occurrence of falls. There was a dearth of 
information in the literature regarding the relationship 
of race to the occurrence of falls except for an earlier 
study conducted in the community that identified White 
race as a risk factor for a serious fall-related injury 
(Tinetti, Doucette, Claus, & Marottoli, 1995). This 
earlier finding was similar to what we found in our 
study of which the group containing White Non-
Hispanics had higher odds of falling. We were not
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Results of Univariate Analysis - Logistic Regression results of Fall Status vs. each Predictor (N = 4978) 
 
Predictor β SE(β) Z p 
Racea     
Asian/Pacific Islander -15.658 1872.033 -0.008 .993 
Black Hispanic -1.329 1.024 -1.298 .194 
Black/African American -1.027 0.410 -2.502 .012 
Other -15.653 939.583 -0.017 .987 
White Hispanic -1.878 0.431 -4.356 .000 
Medication Classb     
Alpha and Beta Adrenergic Agonists 0.952 0.532 1.790 .073 
Ammonia Detoxicants 0.888 0.381 2.330 .020 
Analgesics and Antipyretics  0.475 0.318 1.490 .140 
Angiotensin II Receptor Antagonists  0.545 0.398 1.370 .170 
Antibacterials 0.564 0.366 1.540 .120 
Anticonvulsants  0.957 0.333 2.880 .004 
Antidepressants 0.833 0.333 2.500 .013 
Antiemetics  0.879 0.324 2.710 .007 
Antimuscarinics Antispasmodics  0.727 0.446 1.630 .100 
Antiparkinsonian Agents  1.509 0.610 2.470 .013 
Antiprotozoals  -1.766 1.014 -1.740 .081 
Antitussives 0.747 0.482 1.550 .120 
Antivirals  0.907 0.532 1.710 .088 
Anxiolytics Sedatives and Hypnotics  0.877 0.398 2.200 .028 
Autonomic Drugs Miscellaneous  1.092 0.420 2.600 .009 
Barbiturates  1.658 1.033 1.600 .110 
Benzodiazepines  0.904 0.333 2.720 .007 
Blood Derivatives  0.693 0.531 1.300 .190 
Caloric Agents  0.662 0.446 1.480 .140 
Carbonic Anhydrase Inhibitors  1.836 0.614 2.990 .003 
Cathartics and Laxatives  0.511 0.321 1.590 .110 
Central Alpha Agonists  0.585 0.446 1.310 .190 
Centrally Acting Skeletal Muscle Relaxants  1.539 0.535 2.870 .004 
Diagnostic Agents  1.642 0.536 3.060 .002 
General Anesthetics 1.380 0.448 3.080 .002 
GI Drugs Miscellaneous  4.148 1.235 3.360 .001 
Glycogenolytic Agents  1.503 1.030 1.460 .140 
Immunosuppressive Agents  1.658 1.033 1.600 .110 
Insulins  0.457 0.318 1.440 .150 
Local Anesthetics  1.220 0.420 2.900 .004 
Neuromuscular Blocking Agents  1.540 1.031 1.490 .140 
Opiate Agonists  0.650 0.355 1.830 .067 
Prokinetic Agents 0.847 0.482 1.757 .079 
Replacement Preparations  0.916 0.602 1.523 .128 
Serums  3.048 1.092 2.791 .005 
Somatostatin Agonists  0.931 0.606 1.536 .125 
Thiazide Diuretics  1.060 0.532 1.991 .046 
Vaccines  0.548 0.367 1.492 .136 
Vitamins 0.938 0.325 2.889 .004 
Note.  Criteria for statistical significance:  p < .20: aComparison group is White Non-Hispanic.  bComparison group is absent 
(omitted from the table).  The coding for the medication classes was dichotomous:  1 = present, 0 = absent. 
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Table 4                    
 
Multivariable Logistic Regression Results – Predictors of Fall Status 
 
Predictor β SE(β)  Z p 
Constant -5.848 0.694 -8.429 .000 
Racea     
Black/African American -0.818 0.435 -1.883 .060* 
White Hispanic -1.849 0.474 -3.897 .000* 
Medication Classb     
Alpha and Beta Adrenergic Agonists -0.546 0.788 -0.692 .489 
Ammonia Detoxicants -0.035 0.477 -0.073 .942 
Analgesics and Antipyretics -0.043 0.370 -0.117 .907 
Angiotensin II Receptor Antagonists 0.360 0.448 0.802 .422 
Antibacterials 0.082 0.420 0.195 .845 
Anticonvulsants 0.337 0.380 0.887 .375 
Antidepressants 0.483 0.369 1.308 .191 
Antiemetics 0.743 0.384 1.934 .053* 
Antimuscarinics Antispasmodics -0.272 0.541 -0.502 .616 
Antiparkinsonian Agents 1.532 0.691 2.217 .027* 
Antiprotozoals -2.882 1.106 -2.606 .009* 
Antitussives 0.454 0.544 0.834 .404 
Antivirals 0.484 0.606 0.799 .424 
Anxiolytics Sedatives and Hypnotics 0.529 0.445 1.187 .235 
Autonomic Drugs Miscellaneous 0.867 0.467 1.857 .063* 
Barbiturates 2.152 1.150 1.872 .061* 
Benzodiazepines 0.157 0.382 0.411 .681 
Blood Derivatives 0.004 0.659 0.006 .995 
Caloric Agents 0.039 0.593 0.065 .948 
Carbonic Anhydrase Inhibitors 1.080 0.758 1.424 .154 
Cathartics and Laxatives -0.305 0.389 -0.784 .433 
Central Alpha Agonists 0.115 0.484 0.238 .812 
Centrally Acting Skeletal Muscle Relaxants 1.370 0.595 2.300 .021* 
Diagnostic Agents 2.021 0.674 2.999 .003* 
General Anesthetics 1.295 0.669 1.936 .053* 
GI Drugs Miscellaneous 4.034 1.563 2.582 .010* 
Glycogenolytic Agents 0.704 1.220 0.577 .564 
Immunosuppressive Agents 1.360 1.176 1.156 .248 
Insulins 0.101 0.390 0.259 .795 
Local Anesthetics 0.841 0.477 1.764 .078* 
Neuromuscular Blocking Agents 0.157 1.314 0.120 .905 
Opiate Agonists -0.083 0.419 -0.197 .844 
Prokinetic Agents 0.411 0.552 0.745 .456 
Replacement Preparations 0.178 0.636 0.280 .780 
Serums 2.140 1.316 1.626 .104 
Somatostatin Agonists 0.188 0.712 0.263 .792 
Thiazide Diuretics 1.122 0.608 1.847 .065* 
Vaccines 0.207 0.404 0.513 .608 
Vitamins 0.374 0.377 0.991 .322 
Note.  *Significant at p < .10. aComparison group is “White Non-Hispanic and Others”. bComparison group is absent 
(omitted from the table). The coding for the medication classes was dichotomous:  1 = present, 0 = absent
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Multivariable Logistic Regression Results 
 
Predictor β SE(β) Z p             OR        [95% CI] 
Constant -5.052 1.376 -15.840 0.000 0.006   [0.003 – 0.011] 
Racea 
     
   Black/African American      -0.816 1.518 -1.953 0.051* 0.442   [0.183 – 0.962] 
   White Hispanic     -1.820 1.580 -3.977 0.000 0.162   [0.061 – 0.374] 
Medication Classificationb 
     
   Antiemetics 0.856 1.408 2.499 0.012 2.353   [1.209 – 4.675] 
   Antiparkinsonian Agents 1.512 1.916 2.325 0.020 4.536   [1.017 – 14.115] 
   Antiprotozoals -2.604 2.844 -2.492 0.013 0.074   [0.004 – 0.372] 
   Autonomic Drugs Miscellaneous 0.949 1.553 2.154 0.031 2.583   [1.006 – 0.795] 
   Barbiturates 2.349 3.006 2.134 0.033 10.474   [0.54 – 62.241] 
   Centrally Acting Skeletal Muscle Relaxants 1.531 1.745 2.750 0.006 4.621   [1.323 – 12.398] 
   Diagnostic Agents 1.806 1.869 2.887 0.004 6.086   [1.521 – 18.744] 
   General Anesthetics 1.432 1.601 3.043 0.002 4.187   [1.513 – 9.873] 
   GI Drugs Miscellaneous 3.896 4.814 2.479 0.013 49.185   [1.401 – 983.747] 
   Local Anesthetics 1.013 1.550 2.311 0.021 2.753   [1.077 – 6.15] 
  Thiazide Diuretics 1.205 1.800 2.050 0.040 3.337  [0.878 – 9.357] 
Note.  Criteria for statistical significance: p < .05. *Significant at p < .05 as one of the levels of the Race variable. aComparison 
group is “White Non-Hispanic and Others”.  bComparison group is absent (omitted from the table). The coding for the 
medication classes was dichotomous:  1 = present, 0 = absent. 
surprised by some of the results regarding the impact of 
pharmaceutical agents. A substantial number of drugs 
have been previously identified in the Beers (American 
Geriatrics Society, 2015) list to have an association 
with the incidence of falls. We noted that a larger 
proportion of those who fell received antiemetics or 
insulin compared to those who did not fall. These 
medications are listed in the Beers criteria for 
potentially inappropriate medication use in older adults 
(American Geriatrics Society, 2015).  In our study, 
patients who took antiemetics had 2.4 times higher 
odds of falling. 
Thiazide diuretics were observed to be associated 
with increased odds of falling. Thiazides have been 
associated with falls particularly among women older 
than 70 years of age. It is suspected that a common side 
effect of these drugs, hyponatremia, is responsible 
(Hwang & Kim, 2010).  Patients with symptomatic 
thiazide-induced hyponatremia tend to experience 
muscle weakness, fatigue, and loss of energy which 
may contribute to falls (Liamis, Filippatos, & Elisaf, 
2016; Sardar & Eilbert, 2015). While hyponatremia 
tends to occur most frequently on initiation of therapy, 
it may occur at any time during treatment as a 
consequence of physiological or environmental 
changes (Liamis et al., 2016).  
The study results also indicated that barbiturates 
were associated with increased odds of falling.  
Barbiturates have strong sedative-hypnotic effects even 
at low doses, therefore, causing the following side 
effects: drowsiness, lethargy, dizziness (American 
Geriatrics Society, 2012). This finding was consistent 
with that of Dauphinot et al. (2014) who indicated that 
increased exposure to anticholinergic and sedative 
medications during hospital stay is associated with 
increased risk of inpatient falls. Similarly, Krauss et al. 
(2005) found that the use of sedative-hypnotics was a 
predictor that significantly increased a patient’s risk of 
falling in the hospital.  The study finding that 
administration of central skeletal muscle relaxants 
(SMR) was associated with falls was not surprising. 
These drugs are anticholinergic agents and have 
documented side effects such as confusion and 
sedation, which may lead to falls.   
Antiparkinsonian drugs also increased the odds of 
falling.  Many of the antiparkinsonian agents such as 
Carbidopa-Levodopa may cause dizziness and 
confusion which may contribute to the occurrence of 
falls.  However, the symptoms of Parkinson's disease 
itself including muscular stiffness, freezing, shuffling 
gait, balance impairment or stooped posture make it 
difficult to discern to what extent the antiparkinsonian 
drugs may have contributed to the observed incidence 
of falls (Chen & Swope, 2014).  It has been noted in the 
literature, that gait/balance impairment or lower 
extremity problem was another predictor that 
significantly increased a patient’s risk for falling 
(Krauss et al., 2005).    
Our study revealed that local and general 
anesthetic agents were associated with increased odds 
of falling for patients.   Interestingly, the study of 
Anderson et al. (2014) showed that surgical patients 
were statistically more likely than medical patients to 
sustain a serious fall injury when the category “no 
14
Nursing & Health Sciences Research Journal, Vol. 1, Iss. 1 [2018], Pg. 7-18
https://scholarlycommons.baptisthealth.net/nhsrj/vol1/iss1/4
 
injury” was removed from the analysis. Although the 
research regarding postoperative falls is limited and 
overall incidence is low at 1.6 cases per 10,000 patients 
(Lam et al., 2016), we may expect falls in this 
population because the residual pharmacologic and 
neuromuscular blocking effects of anesthetic agents 
may predispose patients to falls.  Patients who receive 
anesthesia, especially surgical patients, receive a 
combination of agents that have synergistic effects on 
the central nervous system (CNS), neuromuscular and 
GI system that can last for several hours or even days. 
It is worth mentioning that Lam et al. (2016) observed 
that post-anesthesia falls occurred at the bedside 
usually during the day with the presence of clinicians 
and after the first uneventful getting out of bed. 
Although local anesthetic agents such as lidocaine 
patch are not fully systemically absorbed, CNS side 
effects such as fainting, dizziness, weakness, 
confusion, and blurred vision are still reported 
(Drasner, 2015).    
Our study revealed a previously unreported link 
between administration of diagnostic agents and an 
increased odds of falling.  We did not find any prior 
studies associating these drug category to patient falls. 
However, some of the diagnostic agents such as 
diatrizoate meglumine and diatrizoate sodium, have 
high osmolality and are water-soluble (Salix 
Pharmaceuticals, 2016). This may lead to electrolyte 
imbalances, diarrhea and dehydration resulting in 
hypovolemia and hypotension.  This is interesting to 
note because based on this hospital’s previous analysis 
of post-fall data, the most common reason why patients 
fell was toileting. This was consistent with a large scale 
study conducted by Williams et al. (2014) who noted 
that toileting constituted 23% of common patient 
activities at the time of a fall. Special care should be 
taken to adequately hydrate patients before the 
administration of some diagnostic agents to prevent 
dehydration and to offer toileting frequently after the 
procedure. 
Another new finding was the association of 
methylnaltrexone with the incidence of falls.  
Methynaltrexone is a Mu opioid antagonist that is 
indicated for the treatment of opioid-induced 
constipation (Salix Pharmaceuticals, 2016).  It works 
by reducing the constipating effects of opioids without 
impacting the analgesic effects of opioids (Salix 
Pharmaceuticals, 2016).  Because methylnaltrexone 
does not cross the blood-brain barrier, we did not 
expect it to have any impact on falls (Salix 
Pharmaceuticals, 2016). However, we have surmised 
that this is more likely to be the result of its rapid onset 
of action rather than its mechanism of action.  Studies 
have suggested that 30% of patients on 
methylnaltrexone have a bowel movement within 30 
minutes of the first dose (Slatkin et al., 2009; Thomas 
et al., 2008).  One of its known side effects is diarrhea. 
It is possible that falls may occur among some patients 
who suddenly feel the need for toileting and in the 
emergent rush to the bathroom for relief fail to call for 
assistance from staff.  
An interesting finding in this study was that 
antiprotozoal agents were associated with decreased 
odds for falling for the patients. The vast majority of 
the medications administered in this category was 
metronidazole given intravenously or orally.  This 
medication is frequently administered to patients with 
protozoal and bacterial infections. It is also usually 
given for certain gastrointestinal infections such as 
amoebeasis, intra-abdominal infection, Clostridium 
difficile-related diarrhea, Chron’s disease and 
Helicobacter pylori (American Society of Hospital 
Pharmacists, 2016). This was the only drug category 
that lowered the patient’s odds of falling. Perhaps, since 
these medications were given to patients with 
gastrointestinal symptoms, certain precautions have 
already been implemented and more vigilance was 




This is the first study that we know of to examine 
fall-related outcomes among patients deemed at high-
risk for falling in the hospital setting.  It was performed 
using a large sample of 4,978 unique medical records.  
Unlike previous studies, we did not include 
environmental factors (e.g. raised bedrails, non-slip 
footwear, and floor type) because of the ubiquity in the 
implementation of such safety measures within 
hospitals.  By focusing on non-modifiable patient 
characteristics and pharmaceutical treatments, we 
identified a parsimonious list of 12 factors associated 
with falls among high-risk patients. Thus, we expect 
these findings will be amenable for follow-up 
validation studies and eventual translation to the 
practice setting.  
 
Limitations 
This study was conducted at a single hospital, 
therefore the findings may not be readily generalized to 
other populations. As with all observational research, 
our results should not be interpreted to indicate 
causation but rather, association.  Further, the accuracy 
of the results of studies based on medical records data 
are contingent upon the accuracy and completeness of 
the medical record and its abstraction.  In addition, 
during the year covered by our study the facility had a 
low incidence of falls and a large number of patients 
deemed at high-risk for falling, this resulted in an 
unbalanced sample.  We excluded the records of 
patients who did not receive a Morse Fall Scale score 
prior to falling, we cannot say for certain that such 
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patients were not different in some way from those who 
were scored.  
 
Implications 
Certain medications are known risk factors for 
falls, which the literature and the results of this study 
support. Nevertheless, there were certain medication 
classes identified in this research as predictors for falls 
that were not previously identified in the literature.  It 
is important to assure that the bedside clinician knows 
the mechanism and onset of action of these medications 
and implement safety precautions towards falls 
prevention.  For example, certain gastrointestinal 
medications have a rapid onset of action which 
necessitates that toilet facilities should be nearby 
immediately following administration.  Additionally, 
assistance with toileting should also be immediately 
available to patients so as to minimize risk for falls on 
their way to the bathroom. It would further enhance 
patient safety, if patients taking general and even local 
anesthetic medications are flagged so that fall risk 
reassessment can be conducted more frequently.  This 
is particularly important in light of recommendations 
that post-surgical patients are to be encouraged to get 
out-of-bed as early as possible in avoidance of post-
operative pneumonia and other complications. The 
surveillance for fall risk and assistance with ambulation 
should still be offered after the first successful 
ambulation when patients could still be experiencing 
the residual effects of the anesthetic agents.  
The results of this study indicate the need for future 
research regarding predictors for falls among high-risk 
patients.  Replication studies with more balanced 
sample sizes may shed light on the consistency of our 
findings.  Further, there is an opportunity to identify 
subpopulations of patients who are at highest risk by 
examining how necessary treatments may interact and 





Some hospitalized patients fall despite the best 
efforts of individual clinicians and organizations to 
mitigate risk within the care environment. Thus, 
preventing falls will continue to be a patient safety 
imperative in the acute care setting. Due to the 
multifactorial causation of falls, hospitals may need to 
implement several approaches in order to adequately 
address the problem.  Knowledge regarding non-
modifiable patient characteristics and necessary 
pharmacological treatments that predispose patients for 
falling are an invaluable addition to our understanding 
of factors contributing to patient fall-risk as well as the 
improved alignment of safety precautions based on 
individual patient’s needs. 
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